| pubmed-article:21493737 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21493737 | lifeskim:mentions | umls-concept:C0337664 | lld:lifeskim |
| pubmed-article:21493737 | lifeskim:mentions | umls-concept:C2698872 | lld:lifeskim |
| pubmed-article:21493737 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:21493737 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
| pubmed-article:21493737 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:21493737 | pubmed:dateCreated | 2011-7-8 | lld:pubmed |
| pubmed-article:21493737 | pubmed:abstractText | A significant proportion of smokers have lung function impairment characterized by a reduced FEV(1) with a preserved FEV(1)/FVC ratio. These smokers are a poorly characterized group due to their systematic exclusion from chronic obstructive pulmonary disease (COPD) studies. | lld:pubmed |
| pubmed-article:21493737 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21493737 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21493737 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21493737 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21493737 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21493737 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:21493737 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21493737 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:21493737 | pubmed:issn | 1535-4970 | lld:pubmed |
| pubmed-article:21493737 | pubmed:author | pubmed-author:EssawiG HGH | lld:pubmed |
| pubmed-article:21493737 | pubmed:author | pubmed-author:LynchDavid... | lld:pubmed |
| pubmed-article:21493737 | pubmed:author | pubmed-author:ReganElizabet... | lld:pubmed |
| pubmed-article:21493737 | pubmed:author | pubmed-author:CrapoJames... | lld:pubmed |
| pubmed-article:21493737 | pubmed:author | pubmed-author:SilvermanEdwi... | lld:pubmed |
| pubmed-article:21493737 | pubmed:author | pubmed-author:HokansonJohn... | lld:pubmed |
| pubmed-article:21493737 | pubmed:author | pubmed-author:MakeBarry JBJ | lld:pubmed |
| pubmed-article:21493737 | pubmed:author | pubmed-author:WanEmily SES | lld:pubmed |
| pubmed-article:21493737 | pubmed:author | pubmed-author:COPDGene... | lld:pubmed |
| pubmed-article:21493737 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21493737 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:21493737 | pubmed:volume | 184 | lld:pubmed |
| pubmed-article:21493737 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21493737 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21493737 | pubmed:pagination | 57-63 | lld:pubmed |
| pubmed-article:21493737 | pubmed:dateRevised | 2011-9-15 | lld:pubmed |
| pubmed-article:21493737 | pubmed:meshHeading | pubmed-meshheading:21493737... | lld:pubmed |
| pubmed-article:21493737 | pubmed:meshHeading | pubmed-meshheading:21493737... | lld:pubmed |
| pubmed-article:21493737 | pubmed:meshHeading | pubmed-meshheading:21493737... | lld:pubmed |
| pubmed-article:21493737 | pubmed:meshHeading | pubmed-meshheading:21493737... | lld:pubmed |
| pubmed-article:21493737 | pubmed:meshHeading | pubmed-meshheading:21493737... | lld:pubmed |
| pubmed-article:21493737 | pubmed:meshHeading | pubmed-meshheading:21493737... | lld:pubmed |
| pubmed-article:21493737 | pubmed:meshHeading | pubmed-meshheading:21493737... | lld:pubmed |
| pubmed-article:21493737 | pubmed:meshHeading | pubmed-meshheading:21493737... | lld:pubmed |
| pubmed-article:21493737 | pubmed:meshHeading | pubmed-meshheading:21493737... | lld:pubmed |
| pubmed-article:21493737 | pubmed:meshHeading | pubmed-meshheading:21493737... | lld:pubmed |
| pubmed-article:21493737 | pubmed:meshHeading | pubmed-meshheading:21493737... | lld:pubmed |
| pubmed-article:21493737 | pubmed:meshHeading | pubmed-meshheading:21493737... | lld:pubmed |
| pubmed-article:21493737 | pubmed:meshHeading | pubmed-meshheading:21493737... | lld:pubmed |
| pubmed-article:21493737 | pubmed:meshHeading | pubmed-meshheading:21493737... | lld:pubmed |
| pubmed-article:21493737 | pubmed:meshHeading | pubmed-meshheading:21493737... | lld:pubmed |
| pubmed-article:21493737 | pubmed:meshHeading | pubmed-meshheading:21493737... | lld:pubmed |
| pubmed-article:21493737 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21493737 | pubmed:articleTitle | Clinical and radiographic predictors of GOLD-unclassified smokers in the COPDGene study. | lld:pubmed |
| pubmed-article:21493737 | pubmed:affiliation | Channing Laboratory and Pulmonary and Critical Care Division, Brigham and Women’s Hospital, Boston, Massachusetts 02115, USA. reesw@channing.harvard.edu | lld:pubmed |
| pubmed-article:21493737 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21493737 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
